UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+9.04%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$5.59B
AUM Growth
+$865M
(+18%)
Cap. Flow
+$450M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
66.42%
Holding
655
New
83
Increased
132
Reduced
97
Closed
122
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$800M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$386M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
$274M |
| 4 |
DEN
Denbury Inc.
DEN
|
$189M |
| 5 |
VMW
VMware, Inc
VMW
|
$172M |
Top Sells
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Healthcare | 28.93% |
| 3 | Real Estate | 5.18% |
| 4 | Financials | 4.45% |
| 5 | Consumer Discretionary | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALCE
201
DELISTED
Alternus Clean Energy, Inc. Class A Common Stock
ALCE
| $2.35M | 0.04% |
8,902
| – | – |
|
202
DexCom
DXCM
$31.6B
| $2.33M | 0.04% |
+25,000
| New | +$2.33M |
|
203
Insulet
PODD
$24.5B
| $2.3M | 0.04% |
+14,400
| New | +$2.3M |
|
204
Axalta
AXTA
$6.89B
| $2.29M | 0.04% |
85,250
| – | – |
|
205
Alphabet (Google) Class A
GOOGL
$2.84T
| $2.29M | 0.04% |
17,500
-9,500
| -35% | -$1.24M |
|
206
Protagonist Therapeutics
PTGX
$3.77B
| $2.27M | 0.04% |
136,268
+69,174
| +103% | +$1.15M |
|
207
Treace Medical Concepts
TMCI
$453M
| $2.27M | 0.04% |
173,004
+60,551
| +54% | +$794K |
|
|
FNVT
208
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
| $2.27M | 0.04% |
207,992
| – | – |
|
209
Americold
COLD
$3.98B
| $2.27M | 0.04% |
74,510
-14,591
| -16% | -$444K |
|
|
AZEK
210
DELISTED
The AZEK Co
AZEK
| $2.25M | 0.04% |
+75,800
| New | +$2.25M |
|
211
Meta Platforms (Facebook)
META
$1.89T
| $2.25M | 0.04% |
7,500
-21,000
| -74% | -$6.3M |
|
212
AnaptysBio
ANAB
$613M
| $2.24M | 0.04% |
124,463
| – | – |
|
213
Broadstone Net Lease
BNL
$3.53B
| $2.23M | 0.04% |
+155,900
| New | +$2.23M |
|
214
Zymeworks
ZYME
$1.14B
| $2.18M | 0.04% |
344,472
+25,000
| +8% | +$159K |
|
|
MFA
215
MFA Financial
MFA
$1.07B
| $2.18M | 0.04% |
226,894
-78,968
| -26% | -$759K |
|
216
Arvinas
ARVN
$575M
| $2.16M | 0.04% |
110,182
+17,000
| +18% | +$334K |
|
217
AtriCure
ATRC
$1.76B
| $2.16M | 0.04% |
49,293
+9,000
| +22% | +$394K |
|
|
SWTX
218
DELISTED
SpringWorks Therapeutics
SWTX
| $2.16M | 0.04% |
93,236
-22,397
| -19% | -$518K |
|
|
SPEC
219
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
| $2.14M | 0.04% |
192,601
| – | – |
|
220
Oric Pharmaceuticals
ORIC
$1.06B
| $2.13M | 0.04% |
351,502
-10,000
| -3% | -$60.5K |
|
221
Sprinklr
CXM
$1.91B
| $2.08M | 0.04% |
150,000
-118,318
| -44% | -$1.64M |
|
222
Immunocore
IMCR
$1.87B
| $2.04M | 0.04% |
39,345
-1,000
| -2% | -$51.9K |
|
223
iRhythm Technologies
IRTC
$5.82B
| $1.99M | 0.04% |
21,158
+8,629
| +69% | +$813K |
|
|
HCMA
224
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
| $1.99M | 0.04% |
181,263
| – | – |
|
225
Palo Alto Networks
PANW
$130B
| $1.99M | 0.04% |
+17,000
| New | +$1.99M |
|